mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |